Skip to main content

Table 2 Clinical outcomes of pneumonia patients caused by K. pneumoniae

From: Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study

VariableCAP (n = 68)HCAP (n = 74)HAP (n = 134)p value
CAP vs. HCAPHCAP vs. HAPCAP vs. HAP
Appropriate empirical
antimicrobial therapy
64 (94.1)63 (85.1)97 (72.4)0.1040.037< 0.001
Appropriate definite
antimicrobial therapy
61 (89.7)62 (83.8)101 (75.4)0.3000.1580.016
Length of stay after pneumonia, median (IQR), days23.0 (12.5–40.0)23.5
(10.8–41)
16.0
(6.0–39.3)
0.8590.1260.157
Septic shock when pneumonia20 (29.4)33 (44.6)33 (24.6)0.0620.0030.465
Respiratory failure requiring mechanical ventilation32 (47.1)27 (36.5)27 (20.1)0.2020.0100.001
Mortality
 Early mortality (≤48 h)5 (7.4)9 (12.2)20 (14.9)0.3370.5820.122
 28-day mortality19 (27.9)22 (29.7)53 (39.6)0.8140.1580.103
 In-hospital mortality33 (33.8)31 (41.9)65 (48.5)0.3220.3600.047
  1. Data are presented as number (%) of patients, unless stated otherwise
  2. IQR interquartile range, ICU intensive care unit
\